Obesity acts as a confounding factor, not only serving as a potential risk factor for neuroinflammatory diseases such as MS and AD but also inducing leptin resistance through which metabolic dysfunction drives immune dysregulation and neuroinflammation [66]. This evidence concerns the gene LEP and myeloid sarcoma.